e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive
Chad A. Newton, Kiran Batra, Jose Torrealba, Julia Kozlitina, Craig S. Glazer, Carlos Aravena, Keith Meyer, Ganesh Raghu, Harold R. Collard, Christine Kim Garcia
Source:
Eur Respir J 2016; 48: 1710-1720
Journal Issue:
December
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chad A. Newton, Kiran Batra, Jose Torrealba, Julia Kozlitina, Craig S. Glazer, Carlos Aravena, Keith Meyer, Ganesh Raghu, Harold R. Collard, Christine Kim Garcia. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 2016; 48: 1710-1720
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002
Textural analysis demonstrates heterogeneous [
18
F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 52 (5) 1801138; 10.1183/13993003.01138-2018
Year: 2018
Alveoscopy in diffuse interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 244s
Year: 2007
Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Genotype and progressive lung damage in adult cystic fibrosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 502s
Year: 2003
How to diagnose cystic interstitial lung disease
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
Radiology in diffuse parenchymal lung disease and lung nodules
Source: Eur Respir Rev, 26 (144) 170049; 10.1183/16000617.0049-2017
Year: 2017
A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Diffuse parenchymal lung disease
Source: International Congress 2016 – Clinical year in review
Year: 2016
Diffuse parenchymal lung disease
Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017
Year: 2017
Lung clearance index is reproducible and close to normal in stable cystic fibrosis patients post bilateral lung transplant
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept